Novartis Investigative Site

Nampally, Andhra Pradesh 500 001

0 studies enrolling now · 1 studies all time

What they study most

Atherosclerosis

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed